Lansforsakringar Fondforvaltning’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.96M Sell
31,491
-955
-3% -$120K 0.02% 430
2025
Q1
$3.59M Hold
32,446
0.02% 441
2024
Q4
$4.43M Buy
+32,446
New +$4.43M 0.02% 420